Global Pharmacogenomics (PGX) Market Report 2019, Competitive Landscape, Trends and Opportunities
The Pharmacogenomics (PGX) market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Pharmacogenomics (PGX) market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Pharmacogenomics (PGX) market.
Major players in the global Pharmacogenomics (PGX) market include:
23andMe, Inc.
Transgenomic, Inc.
Affymetrix, Inc.
Thermo Fisher Scientific
Pathway Genomics
Illumina, Inc.
GeneTech
Myriad Genetics, Inc.
Abbott Laboratories
OSI Pharmaceuticals
GE Healthcare
GeneDx.
Genset
Pfizer, Inc.
On the basis of types, the Pharmacogenomics (PGX) market is primarily split into:
Microarray
Sequencing
Polymerase Chain Reaction
Others
On the basis of applications, the market covers:
Oncology
Cardiology
Neurological Disorders
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Pharmacogenomics (PGX) market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Pharmacogenomics (PGX) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Pharmacogenomics (PGX) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Pharmacogenomics (PGX) market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Pharmacogenomics (PGX), by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Pharmacogenomics (PGX) in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Pharmacogenomics (PGX) in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Pharmacogenomics (PGX). Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Pharmacogenomics (PGX) market, including the global production and revenue forecast, regional forecast. It also foresees the Pharmacogenomics (PGX) market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Pharmacogenomics (PGX) market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Pharmacogenomics (PGX) market.
Major players in the global Pharmacogenomics (PGX) market include:
23andMe, Inc.
Transgenomic, Inc.
Affymetrix, Inc.
Thermo Fisher Scientific
Pathway Genomics
Illumina, Inc.
GeneTech
Myriad Genetics, Inc.
Abbott Laboratories
OSI Pharmaceuticals
GE Healthcare
GeneDx.
Genset
Pfizer, Inc.
On the basis of types, the Pharmacogenomics (PGX) market is primarily split into:
Microarray
Sequencing
Polymerase Chain Reaction
Others
On the basis of applications, the market covers:
Oncology
Cardiology
Neurological Disorders
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Pharmacogenomics (PGX) market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Pharmacogenomics (PGX) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Pharmacogenomics (PGX) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Pharmacogenomics (PGX) market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Pharmacogenomics (PGX), by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Pharmacogenomics (PGX) in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Pharmacogenomics (PGX) in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Pharmacogenomics (PGX). Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Pharmacogenomics (PGX) market, including the global production and revenue forecast, regional forecast. It also foresees the Pharmacogenomics (PGX) market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 PHARMACOGENOMICS (PGX) MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmacogenomics (PGX)
1.2 Pharmacogenomics (PGX) Segment by Type
1.2.1 Global Pharmacogenomics (PGX) Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Microarray
1.2.3 The Market Profile of Sequencing
1.2.4 The Market Profile of Polymerase Chain Reaction
1.2.5 The Market Profile of Others
1.3 Global Pharmacogenomics (PGX) Segment by Application
1.3.1 Pharmacogenomics (PGX) Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Cardiology
1.3.4 The Market Profile of Neurological Disorders
1.3.5 The Market Profile of Others
1.4 Global Pharmacogenomics (PGX) Market by Region (2014-2026)
1.4.1 Global Pharmacogenomics (PGX) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3 Europe Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.1 Germany Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.2 UK Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.3 France Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.4 Italy Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.5 Spain Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.6 Russia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.7 Poland Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.4 China Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.5 Japan Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.6 India Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8 Central and South America Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Pharmacogenomics (PGX) (2014-2026)
1.5.1 Global Pharmacogenomics (PGX) Revenue Status and Outlook (2014-2026)
1.5.2 Global Pharmacogenomics (PGX) Production Status and Outlook (2014-2026)
2 GLOBAL PHARMACOGENOMICS (PGX) MARKET LANDSCAPE BY PLAYER
2.1 Global Pharmacogenomics (PGX) Production and Share by Player (2014-2019)
2.2 Global Pharmacogenomics (PGX) Revenue and Market Share by Player (2014-2019)
2.3 Global Pharmacogenomics (PGX) Average Price by Player (2014-2019)
2.4 Pharmacogenomics (PGX) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Pharmacogenomics (PGX) Market Competitive Situation and Trends
2.5.1 Pharmacogenomics (PGX) Market Concentration Rate
2.5.2 Pharmacogenomics (PGX) Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 23andMe, Inc.
3.1.1 23andMe, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.1.3 23andMe, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.1.4 23andMe, Inc. Business Overview
3.2 Transgenomic, Inc.
3.2.1 Transgenomic, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.2.3 Transgenomic, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.2.4 Transgenomic, Inc. Business Overview
3.3 Affymetrix, Inc.
3.3.1 Affymetrix, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.3.3 Affymetrix, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.3.4 Affymetrix, Inc. Business Overview
3.4 Thermo Fisher Scientific
3.4.1 Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.4.3 Thermo Fisher Scientific Pharmacogenomics (PGX) Market Performance (2014-2019)
3.4.4 Thermo Fisher Scientific Business Overview
3.5 Pathway Genomics
3.5.1 Pathway Genomics Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.5.3 Pathway Genomics Pharmacogenomics (PGX) Market Performance (2014-2019)
3.5.4 Pathway Genomics Business Overview
3.6 Illumina, Inc.
3.6.1 Illumina, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.6.3 Illumina, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.6.4 Illumina, Inc. Business Overview
3.7 GeneTech
3.7.1 GeneTech Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.7.3 GeneTech Pharmacogenomics (PGX) Market Performance (2014-2019)
3.7.4 GeneTech Business Overview
3.8 Myriad Genetics, Inc.
3.8.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.8.4 Myriad Genetics, Inc. Business Overview
3.9 Abbott Laboratories
3.9.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.9.3 Abbott Laboratories Pharmacogenomics (PGX) Market Performance (2014-2019)
3.9.4 Abbott Laboratories Business Overview
3.10 OSI Pharmaceuticals
3.10.1 OSI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.10.3 OSI Pharmaceuticals Pharmacogenomics (PGX) Market Performance (2014-2019)
3.10.4 OSI Pharmaceuticals Business Overview
3.11 GE Healthcare
3.11.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.11.3 GE Healthcare Pharmacogenomics (PGX) Market Performance (2014-2019)
3.11.4 GE Healthcare Business Overview
3.12 GeneDx.
3.12.1 GeneDx. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.12.3 GeneDx. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.12.4 GeneDx. Business Overview
3.13 Genset
3.13.1 Genset Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.13.3 Genset Pharmacogenomics (PGX) Market Performance (2014-2019)
3.13.4 Genset Business Overview
3.14 Pfizer, Inc.
3.14.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.14.3 Pfizer, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.14.4 Pfizer, Inc. Business Overview
4 GLOBAL PHARMACOGENOMICS (PGX) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Pharmacogenomics (PGX) Production and Market Share by Type (2014-2019)
4.2 Global Pharmacogenomics (PGX) Revenue and Market Share by Type (2014-2019)
4.3 Global Pharmacogenomics (PGX) Price by Type (2014-2019)
4.4 Global Pharmacogenomics (PGX) Production Growth Rate by Type (2014-2019)
4.4.1 Global Pharmacogenomics (PGX) Production Growth Rate of Microarray (2014-2019)
4.4.2 Global Pharmacogenomics (PGX) Production Growth Rate of Sequencing (2014-2019)
4.4.3 Global Pharmacogenomics (PGX) Production Growth Rate of Polymerase Chain Reaction (2014-2019)
4.4.4 Global Pharmacogenomics (PGX) Production Growth Rate of Others (2014-2019)
5 GLOBAL PHARMACOGENOMICS (PGX) MARKET ANALYSIS BY APPLICATION
5.1 Global Pharmacogenomics (PGX) Consumption and Market Share by Application (2014-2019)
5.2 Global Pharmacogenomics (PGX) Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Pharmacogenomics (PGX) Consumption Growth Rate of Oncology (2014-2019)
5.2.2 Global Pharmacogenomics (PGX) Consumption Growth Rate of Cardiology (2014-2019)
5.2.3 Global Pharmacogenomics (PGX) Consumption Growth Rate of Neurological Disorders (2014-2019)
5.2.4 Global Pharmacogenomics (PGX) Consumption Growth Rate of Others (2014-2019)
6 GLOBAL PHARMACOGENOMICS (PGX) PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Pharmacogenomics (PGX) Consumption by Region (2014-2019)
6.2 United States Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.3 Europe Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.4 China Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.5 Japan Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.6 India Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
7 GLOBAL PHARMACOGENOMICS (PGX) PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Pharmacogenomics (PGX) Production and Market Share by Region (2014-2019)
7.2 Global Pharmacogenomics (PGX) Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
8 PHARMACOGENOMICS (PGX) MANUFACTURING ANALYSIS
8.1 Pharmacogenomics (PGX) Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Pharmacogenomics (PGX)
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Pharmacogenomics (PGX) Industrial Chain Analysis
9.2 Raw Materials Sources of Pharmacogenomics (PGX) Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Pharmacogenomics (PGX)
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL PHARMACOGENOMICS (PGX) MARKET FORECAST (2019-2026)
11.1 Global Pharmacogenomics (PGX) Production, Revenue Forecast (2019-2026)
11.1.1 Global Pharmacogenomics (PGX) Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Pharmacogenomics (PGX) Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Pharmacogenomics (PGX) Price and Trend Forecast (2019-2026)
11.2 Global Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Pharmacogenomics (PGX) Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Pharmacogenomics (PGX) Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Pharmacogenomics (PGX)
1.2 Pharmacogenomics (PGX) Segment by Type
1.2.1 Global Pharmacogenomics (PGX) Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Microarray
1.2.3 The Market Profile of Sequencing
1.2.4 The Market Profile of Polymerase Chain Reaction
1.2.5 The Market Profile of Others
1.3 Global Pharmacogenomics (PGX) Segment by Application
1.3.1 Pharmacogenomics (PGX) Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Cardiology
1.3.4 The Market Profile of Neurological Disorders
1.3.5 The Market Profile of Others
1.4 Global Pharmacogenomics (PGX) Market by Region (2014-2026)
1.4.1 Global Pharmacogenomics (PGX) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3 Europe Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.1 Germany Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.2 UK Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.3 France Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.4 Italy Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.5 Spain Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.6 Russia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.3.7 Poland Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.4 China Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.5 Japan Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.6 India Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8 Central and South America Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Pharmacogenomics (PGX) Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Pharmacogenomics (PGX) (2014-2026)
1.5.1 Global Pharmacogenomics (PGX) Revenue Status and Outlook (2014-2026)
1.5.2 Global Pharmacogenomics (PGX) Production Status and Outlook (2014-2026)
2 GLOBAL PHARMACOGENOMICS (PGX) MARKET LANDSCAPE BY PLAYER
2.1 Global Pharmacogenomics (PGX) Production and Share by Player (2014-2019)
2.2 Global Pharmacogenomics (PGX) Revenue and Market Share by Player (2014-2019)
2.3 Global Pharmacogenomics (PGX) Average Price by Player (2014-2019)
2.4 Pharmacogenomics (PGX) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Pharmacogenomics (PGX) Market Competitive Situation and Trends
2.5.1 Pharmacogenomics (PGX) Market Concentration Rate
2.5.2 Pharmacogenomics (PGX) Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 23andMe, Inc.
3.1.1 23andMe, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.1.3 23andMe, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.1.4 23andMe, Inc. Business Overview
3.2 Transgenomic, Inc.
3.2.1 Transgenomic, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.2.3 Transgenomic, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.2.4 Transgenomic, Inc. Business Overview
3.3 Affymetrix, Inc.
3.3.1 Affymetrix, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.3.3 Affymetrix, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.3.4 Affymetrix, Inc. Business Overview
3.4 Thermo Fisher Scientific
3.4.1 Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.4.3 Thermo Fisher Scientific Pharmacogenomics (PGX) Market Performance (2014-2019)
3.4.4 Thermo Fisher Scientific Business Overview
3.5 Pathway Genomics
3.5.1 Pathway Genomics Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.5.3 Pathway Genomics Pharmacogenomics (PGX) Market Performance (2014-2019)
3.5.4 Pathway Genomics Business Overview
3.6 Illumina, Inc.
3.6.1 Illumina, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.6.3 Illumina, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.6.4 Illumina, Inc. Business Overview
3.7 GeneTech
3.7.1 GeneTech Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.7.3 GeneTech Pharmacogenomics (PGX) Market Performance (2014-2019)
3.7.4 GeneTech Business Overview
3.8 Myriad Genetics, Inc.
3.8.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.8.4 Myriad Genetics, Inc. Business Overview
3.9 Abbott Laboratories
3.9.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.9.3 Abbott Laboratories Pharmacogenomics (PGX) Market Performance (2014-2019)
3.9.4 Abbott Laboratories Business Overview
3.10 OSI Pharmaceuticals
3.10.1 OSI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.10.3 OSI Pharmaceuticals Pharmacogenomics (PGX) Market Performance (2014-2019)
3.10.4 OSI Pharmaceuticals Business Overview
3.11 GE Healthcare
3.11.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.11.3 GE Healthcare Pharmacogenomics (PGX) Market Performance (2014-2019)
3.11.4 GE Healthcare Business Overview
3.12 GeneDx.
3.12.1 GeneDx. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.12.3 GeneDx. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.12.4 GeneDx. Business Overview
3.13 Genset
3.13.1 Genset Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.13.3 Genset Pharmacogenomics (PGX) Market Performance (2014-2019)
3.13.4 Genset Business Overview
3.14 Pfizer, Inc.
3.14.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
3.14.3 Pfizer, Inc. Pharmacogenomics (PGX) Market Performance (2014-2019)
3.14.4 Pfizer, Inc. Business Overview
4 GLOBAL PHARMACOGENOMICS (PGX) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Pharmacogenomics (PGX) Production and Market Share by Type (2014-2019)
4.2 Global Pharmacogenomics (PGX) Revenue and Market Share by Type (2014-2019)
4.3 Global Pharmacogenomics (PGX) Price by Type (2014-2019)
4.4 Global Pharmacogenomics (PGX) Production Growth Rate by Type (2014-2019)
4.4.1 Global Pharmacogenomics (PGX) Production Growth Rate of Microarray (2014-2019)
4.4.2 Global Pharmacogenomics (PGX) Production Growth Rate of Sequencing (2014-2019)
4.4.3 Global Pharmacogenomics (PGX) Production Growth Rate of Polymerase Chain Reaction (2014-2019)
4.4.4 Global Pharmacogenomics (PGX) Production Growth Rate of Others (2014-2019)
5 GLOBAL PHARMACOGENOMICS (PGX) MARKET ANALYSIS BY APPLICATION
5.1 Global Pharmacogenomics (PGX) Consumption and Market Share by Application (2014-2019)
5.2 Global Pharmacogenomics (PGX) Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Pharmacogenomics (PGX) Consumption Growth Rate of Oncology (2014-2019)
5.2.2 Global Pharmacogenomics (PGX) Consumption Growth Rate of Cardiology (2014-2019)
5.2.3 Global Pharmacogenomics (PGX) Consumption Growth Rate of Neurological Disorders (2014-2019)
5.2.4 Global Pharmacogenomics (PGX) Consumption Growth Rate of Others (2014-2019)
6 GLOBAL PHARMACOGENOMICS (PGX) PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Pharmacogenomics (PGX) Consumption by Region (2014-2019)
6.2 United States Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.3 Europe Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.4 China Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.5 Japan Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.6 India Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Pharmacogenomics (PGX) Production, Consumption, Export, Import (2014-2019)
7 GLOBAL PHARMACOGENOMICS (PGX) PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Pharmacogenomics (PGX) Production and Market Share by Region (2014-2019)
7.2 Global Pharmacogenomics (PGX) Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Pharmacogenomics (PGX) Production, Revenue, Price and Gross Margin (2014-2019)
8 PHARMACOGENOMICS (PGX) MANUFACTURING ANALYSIS
8.1 Pharmacogenomics (PGX) Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Pharmacogenomics (PGX)
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Pharmacogenomics (PGX) Industrial Chain Analysis
9.2 Raw Materials Sources of Pharmacogenomics (PGX) Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Pharmacogenomics (PGX)
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL PHARMACOGENOMICS (PGX) MARKET FORECAST (2019-2026)
11.1 Global Pharmacogenomics (PGX) Production, Revenue Forecast (2019-2026)
11.1.1 Global Pharmacogenomics (PGX) Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Pharmacogenomics (PGX) Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Pharmacogenomics (PGX) Price and Trend Forecast (2019-2026)
11.2 Global Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Pharmacogenomics (PGX) Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Pharmacogenomics (PGX) Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Pharmacogenomics (PGX) Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
